SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.53-3.5%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Lamb who wrote (6730)1/18/1999 11:11:00 PM
From: BigKNY3  Read Replies (2) of 9523
 
Viagra 's Popular, But Most Consumers Don't Remember Drug Names

01/18/99
Dow Jones Business News

NEW YORK -(Dow Jones)- U.S. consumers recognize the name of Pfizer Inc.'s Viagra more than any other drug, and Merck & Co. Inc. has the most-recognizable corporate name in the business, according to a survey released Monday. But for the most part, the names of drugs and drugmakers don't stick with Americans at all, the study shows.

Scott-Levin, a Newtown, Pa.-based market-research firm, surveyed 1,400 consumers in its annual study. Scott Levin is a unit of PMSI Scott-Levin Inc., which recently agreed to be acquired by Quintiles Transnational Corp. (QTRN).

Only 37% of the consumers could recall any product names from news stories, and only 23% were able to name a specific drug company. Consumers were more likely to be able to mention a product or company by name if they were chronic users of prescription drugs, 55 or older, college graduates, or medically educated.

The name Viagra , the blockbuster impotence drug that Pfizer (PFE) put on the market last year, was recognized by 34% of the respondents in Scott-Levin's survey.

Next was Pondimin, the brand name of fenfluramine, the diet drug sold by American Home Products Corp.'s (AHP) Wyeth-Ayerst. The drug, which was pulled off the market in 1997 after medical studies found a link to heart disease, was recognized by 8% of those surveyed.

Schering-Plough Corp.'s (SGP) antihistamine Claritin was recognized by 7%, while 5% said they had heard of Eli Lilly & Co.'s (LLY) antidepressant Prozac.

The most-recognized drug makers were Merck (MRK), at 13%; Pfizer, at 12%; Lilly, at 9%; Bristol-Myers Squibb Co. (BMY), at 8%; Glaxo Wellcome PLC (GLX), at 6%; and American Home Products, at 5%.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext